Whitener Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.55M Buy
2,960
+1,309
+79% +$1.34M 0.75% 31
2026
Q1
$1.52M Buy
1,651
+193
+13% +$196K 0.35% 60
2025
Q4
$1.57M Buy
1,458
+11
+0.8% +$10.5K 0.36% 58
2025
Q3
$1.1M Sell
1,447
-27
-2% -$20.1K 0.26% 74
2025
Q2
$1.15M Sell
1,474
-7
-0.5% -$5.44K 0.3% 67
2025
Q1
$1.22M Sell
1,481
-338
-19% -$281K 0.35% 62
2024
Q4
$1.4M Sell
1,819
-44
-2% -$36.4K 0.39% 55
2024
Q3
$1.65M Buy
1,863
+268
+17% +$241K 0.47% 51
2024
Q2
$1.44M Buy
1,595
+187
+13% +$150K 0.44% 50
2024
Q1
$1.1M Buy
1,408
+212
+18% +$151K 0.36% 61
2023
Q4
$697K Buy
+1,196
New +$698K 0.25% 75
2019
Q4
Sell
-31
Closed -$3K 305
2019
Q3
$3K Buy
+31
New +$3.45K ﹤0.01% 427
2019
Q1
Sell
-550
Closed -$63K 490
2018
Q4
$63K Hold
550
0.05% 173
2018
Q3
$59K Buy
+550
New +$55K 0.04% 186
2018
Q2
Sell
-550
Closed -$42K 276
2018
Q1
$42K Hold
550
0.03% 213
2017
Q4
$46K Buy
+550
New +$46.8K 0.04% 193

Other funds holding LLY

Whitener Capital Management's LLY Position: Q2 2026 in Review

Whitener Capital Management increased its Eli Lilly (LLY) stake by 79% in Q2 2026, buying an estimated $1.34M and bringing the position to 2,960 shares worth $3.55M. The position accounts for 0.75% of the portfolio, ranked #31.

Whitener Capital Management first reported a position in LLY in Q4 2017 and has held it in 16 quarters since. 1,945 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Whitener Capital Management held 2,960 shares of Eli Lilly worth $3.55M as of Q2 2026.
  • Whitener Capital Management bought 1,309 Eli Lilly shares in Q2 2026, an estimated $1.34M.
  • Eli Lilly made up 0.75% of Whitener Capital Management's portfolio in Q2 2026, its #31 holding.
  • Whitener Capital Management first reported a position in Eli Lilly in Q4 2017 and has held it in 16 quarters since.
  • 1,945 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Whitener Capital Management's 13F filing for Q2 2026, filed 10 Jul 2026.